Health ❯ Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Phase 3 Trials

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

Pfizer signals regulatory plans after a congress presentation of the data.

FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of High‑Risk CSCC

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study